Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Exploring depression in schizophrenia.

Carlo Maggini1, Andrea Raballo

  • 1Psychiatry Section, Department of Neuroscience, University of Parma, Piazzale Matteotti, 43100 Parma, Italy. carlo.maggini@unipr.it

European Psychiatry : the Journal of the Association of European Psychiatrists
|December 17, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Altered mirroring and self-face processing in schizophrenia: A systematic review.

Schizophrenia research·2026
Same author

Ipseity-Disturbance and the Nature of Self-Disorder in Schizophrenia: Clarifying Conceptual and Empirical Foundations (a Constructive Reply to Feyaerts and Sass).

Schizophrenia bulletin·2026
Same author

Familial high-risk (FHR) for severe mental illness in clinical high-risk for psychosis (CHR-P): a systematic review and meta-analysis.

European archives of psychiatry and clinical neuroscience·2026
Same author

Rethinking the p-factor: A model of cumulative risk aggregation across development-Commentary on Caspi et al. (2026).

Journal of psychopathology and clinical science·2026
Same author

Antidepressants and Psychosis Risk: Disentangling Causal Effects From Prognostic Signals.

Acta psychiatrica Scandinavica·2026
Same author

Spatial disruptions and the embodied Self in schizophrenia: toward a developmental framework.

Schizophrenia (Heidelberg, Germany)·2026
Same journal

Predictors of Conversion from Major Depressive Disorder to Bipolar Disorder: A Population-Based PADRIS-PRESTO Cohort Study in Catalonia.

European psychiatry : the journal of the Association of European Psychiatrists·2026
Same journal

Precision medicine in mental health: applications, challenges, and recommendations - CORRIGENDUM.

European psychiatry : the journal of the Association of European Psychiatrists·2026
Same journal

Real-world effectiveness and safety of intranasal esketamine for treatment-resistant depression: data from the enTRD registry.

European psychiatry : the journal of the Association of European Psychiatrists·2026
Same journal

Trajectory of response to esketamine nasal spray for treatment resistant depression: findings from ESCAPE-TRD.

European psychiatry : the journal of the Association of European Psychiatrists·2026
Same journal

Identification of distinct clinical phenotypes and their neurobiological signatures in stress-exposed individuals: A multimodal machine learning approach.

European psychiatry : the journal of the Association of European Psychiatrists·2026
Same journal

The interplay among narcissistic vulnerability, interpersonal sensitivity, and metacognitive integration: A network analysis approach.

European psychiatry : the journal of the Association of European Psychiatrists·2026
See all related articles

This study found the Calgary depression scale for schizophrenia (CDSS) has three factors: depression-hopelessness, guilt, and early wakening. The first two factors correlate with schizophrenia symptoms and subjective experiences.

Area of Science:

  • Psychiatry
  • Clinical Psychology

Background:

  • Depression significantly impacts quality of life and social functioning in schizophrenia.
  • Depression is a crucial factor influencing treatment strategies, outcomes, and prognosis in schizophrenia patients.

Purpose of the Study:

  • To investigate the factorial structure of the Calgary depression scale for schizophrenia (CDSS).
  • To explore the relationships between CDSS factors, major schizophrenic symptom dimensions, and subjective experiences.

Main Methods:

  • 161 schizophrenic patients were assessed.
  • Schizophrenic symptom severity was scored using the five-dimensional model.
  • Distress from negative symptoms and subjective cognitive-affective vulnerability (basic symptoms) were evaluated.

Related Experiment Videos

Main Results:

  • Principal component analysis identified three main factors in the CDSS: "depression-hopelessness" (Factor I), "guilty idea of reference-pathological guilt" (Factor II), and "early wakening" (Factor III).
  • Factor III (early wakening) did not correlate with other psychopathological domains.
  • Factors I and II showed significant correlations with both diagnostic symptoms and subjective experiences.

Conclusions:

  • The findings confirm a threefold factorial structure for the CDSS.
  • The results illuminate the psychopathological nature of depression components in schizophrenia.
  • Distinct correlation patterns support the clinical differentiation between a general "depression-hopelessness" factor and a "guilty idea of reference-pathological guilt" factor.